Are ‘The Munchies' Real? Cannabis, Science, Food & Flavor, Explained
What are the munchies—and why does weed increase appetite in such a specific, intense way? This ... More explainer breaks down the biology, cravings, and cultural meaning behind the foods we reach for when we're high.
Yes, it's more than a meme. The 'munchies' effect—those sudden, often intense cravings for salty, sweet, or high-fat snacks after cannabis use—isn't just anecdotal. It's biological.
According to a 2009 study in Nature Neuroscience, cannabis compounds activate the brain's endocannabinoid system, which heightens our senses of smell and taste. That sensory boost makes food more appealing and can override the body's natural signals of fullness. THC also promotes the release of the hunger hormone ghrelin, which further stimulates appetite and encourages food-seeking behavior. In short, weed doesn't just make you hungry—it makes food feel more vivid, more rewarding, and harder to resist.
But it's not just about flavor. A 2019 study in the Journal of Psychopharmacology found that cannabis also increases dopamine activity in the striatum, the part of the brain that controls reward-seeking behavior. So the munchies aren't just a reaction—they're a reward loop. A full-body yes to whatever feels good, fast, and easy. That said, the effect isn't one-size-fits-all. Chronic cannabis use can alter how the reward system responds over time, and not all users experience the same intensity of dopamine-driven food desire.
That might explain why cannabis-friendly food holidays like 4/20 have become unofficial showcases for fast-food indulgence. From extra-cheesy nachos to triple-patty burgers, the food isn't just functional—it's engineered to satisfy every level. The appeal is emotional as much as it is physical. A craving, yes—but also a comfort.
Fast food and weed go hand in hand—but it's not random. When you get the munchies, you're looking ... More for comfort, ease, and something that hits all your flavor buttons fast.
But the munchies don't happen in a vacuum. What we reach for when that craving hits is shaped by something else entirely: culture. And in 2025, that culture is increasingly fast, familiar, and available through an app.
A recent Tastewise survey found that 75% of Americans eat fast food at least once a week. Among Gen Z and Millennials, nearly half say they're eating more fast food than they were just a year ago. Their top reasons? Cravings, comfort, and convenience.
That trifecta is also the blueprint for a munchies meal. Salty. Satisfying. No prep required. So when 4/20 rolls around, it's not just a stoner holiday anymore. It's a high-demand food moment—one where brands can lean into what consumers are already doing when they're tired, overstimulated, or emotionally frayed: reaching for something hot, fast, and reliable.
The munchies aren't just slang. From global health surveys to neuroscience labs, researchers are ... More treating cannabis-induced appetite as a serious behavior worth tracking.
What used to be whispered about is now tracked in government databases. In the latest WHO Global School-based Student Health Survey, cannabis use is listed right alongside fast food, soda, and physical activity as a behavioral health metric.
That might not seem groundbreaking on its face. But it points to a broader shift in how cannabis is framed—not as moral failure, but as measurable behavior. Not as deviance but as data.
That shift matters. When public health frameworks start treating cannabis use the same way they treat food frequency or screen time, brands are quick to follow. Not with warnings—but with promotions. With late-night bundles. With stoner-safe snacks that feel more like self-care than vice.
Who gets the munchies? Not just teens or stereotypes. With cannabis use up across Millennials and ... More Gen X, this appetite shift is changing the way we snack, crave, and connect to food.
That normalization shows up in the numbers, too. According to Gallup, 16% of U.S. adults said they smoke marijuana in 2022—up from just 7% in 2013. That's a doubling in less than a decade, thanks to legalization, cultural softening, and a generational shift in what cannabis means.
It's not just a niche anymore. It's mainstream. And fast food brands are watching.
For Millennials and Gen Z—many of whom came of age alongside dispensary menus and infused gummies—4/20 doesn't feel transgressive. It feels like a craving calendar. And the brands lining up to feed it? They know it's not just about the weed. It's about what comes after. The bite. The hit. The relief.
Cannabis cravings don't always lead to junk food—and they aren't always unhealthy. As brands race to ... More meet 4/20 appetites, they're missing how deeply personal the munchies can be.
Cannabis users aren't fringe anymore—and brands know it.
In recent years, everyone from Taco Bell to Jack in the Box to Fatburger has rolled out food and drink promotions that nod to the 4/20 crowd without saying the quiet part out loud. The strategy is familiar: bigger, bolder, cheesier. Add more sauces. Name it something slightly chaotic. Drop it after 10 p.m.
And yes—it's working. According to a recent GlobalData survey, early findings show a potential rise in the consumption of savory snacks, chocolate, and confectionery, especially in North America. Unlike the energy drink space, where Gen Z dominates, these snack spikes are driven largely by older Millennials and Gen X.
In other words, the munchies market isn't just younger—it's broader. And it's reshaping what indulgence looks like across demographics.
The relationship between cannabis, appetite, and health isn't as linear as it looks. While cannabis clearly heightens cravings, studies suggest it isn't necessarily linked to obesity—and may even correlate with lower diabetes risk. That tension between indulgence and impact complicates the old narratives. The munchies aren't just about eating more. They might be about eating differently—or seeking out satisfaction on entirely different terms.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Letters: He overdosed after being turned away by S.F. drug treatment center. Mother seeks answers
Jonathan Martin, my son, overdosed after he was turned away from HealthRight360's detox facility on Aug. 27, 2024. Jonathan was desperately ill and seeking help. He died alone early the next morning. Jonathan's death was the subject of a Chronicle story ('He overdosed waiting for help. Why did S.F.'s largest drug treatment center provider turn him away?' San Francisco, Feb. 27). When the story was published, I sent a letter to Mayor Daniel Lurie, District Attorney Brooke Jenkins, the chiefs of the Department of Public Health and relevant agencies, HealthRight360 CEO Vitka Eisen and every member of the Board of Supervisors, hoping to find out why my son was turned away. I wanted to understand what prevented him from receiving the services he so urgently needed. I have still not received a single response, explanation or even a note of condolence from any of these officials. If the people who oversee drug treatment in the city will not answer a grieving mother, who will give my family answers? Citizens of San Francisco: You voted these people into office. Is this how you want your loved one to be treated while trying to seek help? The silence from those in power is deafening. Our family demands answers. Carolyn Stueve-Martin, Tulsa, Okla. Don't hide Pride I empathize with her desire for concealment, misdirection or camouflage during a time of danger. My wife is trans, and this is a scary time for us. But I am afraid that Judd is missing the purpose of Pride entirely. Pride is not about shame. It's not about showing off our most socially acceptable community members in the hopes that bigots will leave the rest alone. It is the bigots who should be ashamed. A Pride celebration that is ashamed of its trans and genderqueer members — who are, as Judd wrote, just people trying to live their lives openly and freely — is no Pride at all. Amanda Seyfer, Oakland Big Brother rising Technology has always been a double-edged sword. Fire can provide warmth and light, but it can also be used to burn down an enemy village. IBM's punch cards helped make Social Security possible, but also enabled Hitler's destruction of European Jewry. Today, a shadowy Bay Area company called Palantir is coalescing federal government information on Americans into a database that would allow it to target anyone who dissents from its autocratic policies or has characteristics that it does not favor. We need our representatives (or the courts) to block this monstrous machine before it rolls over us and makes this country a new Reich just like the old Reich.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
New Alzheimer's blood tests make diagnosis easier — but they're not right for everyone
The number of Americans with Alzheimer's disease, the most common cause of dementia in the U.S., is projected to rise significantly in the coming decades. The devastating disease has no cure, but the past several years have brought promising developments in new drug therapies and blood tests that help doctors treat and diagnose the disease. Here's what to know about the blood tests that diagnose Alzheimer's, one of which got full FDA approval in May. How they work Several commercially available blood tests have become available the past few years, most recently from biotech company Fujirebio Diagnostics, which got full approval from the FDA last month. Each test measures slightly different things, but overall they look for abnormal levels of certain proteins — amyloid and tau — in the blood. The accumulation of amyloid and tau proteins in the brain, often called plaques, are hallmark signs of Alzheimer's. If someone has tau plaques in the brain, for instance, some of that will leak out of the brain into the blood, resulting in a blood test result showing higher than normal levels of tau. In patients with symptoms of cognitive impairment, the tests predict an Alzheimer's diagnosis with about 90% accuracy. Why they're important The blood tests are a notable development because they are less expensive and less invasive than other types of testing that doctors have long used to diagnose patients with Alzheimer's. One is a PET scan, which involves injecting a patient with a radioactive tracer that binds to amyloid or tau in the brain so the presence of the proteins can be seen in a scan. It can cost several thousand dollars, compared to several hundred dollars for a blood test. The other is a spinal tap, which is painful or uncomfortable for many people. This method measures different forms of amyloid and tau in the spinal fluid. 'Up until these blood tests came out, a physician was stuck doing a PET scan or spinal tap, so not great options,' said Dr. Frank Longo, a professor of neurology at Stanford Medicine. 'The big breakthrough is finding something to measure in the blood that's about 90% accurate of what's going on in the brain, about as accurate as spinal fluid or a PET scan.' Doctors use the blood test as part of a broader medical evaluation that also includes a patient history, neurological exam and other testing. The blood test can help rule out Alzheimer's as the cause of a patient's cognitive impairment and potentially avoid unnecessary further testing. If someone's blood test comes back normal, for example, they may not have to undergo the PET scan or spinal tap, and their doctor can look into other potential causes of the cognitive impairment. 'That's the biggest practical thing it's doing now,' Longo said. It's important to distinguish Alzheimer's from other types of dementia because there are Alzheimer's treatments that have come out the last few years that help slow the progression of Alzheimer's. But patients must be in relatively early stages of the disease, with mild impairment or mild dementia, to be eligible. Some of the therapies have significant side effects, so patients would not want to start them unless they knew it was Alzheimer's, and not something else, causing the dementia. They're not for everyone The tests are approved only for people who already have symptoms of cognitive impairment and are of a certain age — 55 and over or 60 and over, depending on the test. They are not approved for healthy adults with normal cognition who want to diagnose or rule out Alzheimer's, or who are simply curious if they are at risk for developing Alzheimer's. They must be ordered by a doctor. They're becoming more common, but may not be covered by insurance Some of the blood tests have been available for a year or two, Longo said, but they were under an earlier and more limited type of FDA approval, not the full approval that the agency granted last month to the Fujirebio test. So they are poised to become more common. 'A year ago, most of my colleagues and I were not ordering these,' Longo said. 'I'd say less than 5% or 10% of the time we were ordering these. Now people are starting to order them in symptomatic patients. It's not rare now. They're starting to be recognized more.' Some primary care doctors are starting to order the tests as well, said Dr. Armen Moughamian, medical director of Sutter Health's Ray Dolby Brain Center at CPMC in San Francisco. The center treats patients with memory disorders. 'It's definitely a minority, but I've been seeing it done,' he said. As with many new medical tests, insurers may not cover them yet, but that usually evolves over time. Full FDA approval may help make the case for the tests to be covered, Longo said. 'There is some uncertainty and lack of clarity about whether insurance and Medicare pay,' Moughamian said. 'That creates some hesitancy for providers to order it.' They may one day be used to screen and diagnose healthy people earlier In people with Alzheimer's, amyloid plaques begin to form in the brain as many as 20 years before they show symptoms. Right now, newer therapies for Alzheimer's — like lecanemab and donanemab, which slow the progression of the disease — are approved only for people with symptoms. Those symptoms are mild cognitive impairment or mild dementia, the early stages of symptomatic Alzheimer's. This means people who have not yet developed symptoms, but who have amyloid plaques in the brain, cannot get these treatments. So if a blood test could be used in pre-symptomatic people, it could mean better screening and earlier diagnosis to larger groups of people. 'What we want to push for is earlier diagnosis because new therapies are available when we catch people in earlier stages,' Moughamian said. Moughamian is leading two clinical trials that examine whether drugs that remove amyloid in the brain, donanemab and another drug remternetug, can work in people who have amyloid plaques but have not yet developed symptoms. They are using an Alzheimer's blood test to see whether patients are eligible for the trial.
Business Insider
2 hours ago
- Business Insider
Millennials are embracing compression socks — and trying to make them cool
Hot girls wear…compression socks? Designed to help reduce inflammation and increase blood flow, the once-niche, medical-grade product is frequently spotted in nursing homes and hospitals. Now, compression socks are becoming increasingly popular among millennials and Gen Zers. It shouldn't surprise anyone who has been paying attention to the former's shopping habits. Millennials are big fans of products that promote longevity and help them be proactive about their health. They sport Apple watches, bring earplugs to concerts, and track their VO2 max when they work out. Sock brands are capitalizing on consumer interest with stylish new designs that are far from your grandma's compression socks, combining the benefits of compression with fashion cute enough for TikTok. Here's why younger audiences can't get enough. Compression socks go mainstream Kate Garfield, the 38-year-old co-owner of Violet Hour Pilates in Brooklyn, told Business Insider she's been regularly wearing compression socks to teach Pilates since she sprained her ankle a few years ago. She also pulls the socks out for long-haul flights. "When I was barefoot and teaching, I kept twinging my ankle, so I started wearing them," Garfield said. "It definitely helped in that recovery, but then I noticed I was also just feeling a lot more energized through my day." Wearing compression socks, Garfield said she doesn't feel the urge to clench and roll her feet, which helps her feel more stable. She can leave a full day of teaching without feeling sore. So, how do they work? Standing, sitting, or lying down for a long time can cause blood to pool in the feet and lower legs, creating swelling and discomfort. Compression socks encourage the blood to get moving again by putting pressure near the foot and ankle and gentler pressure up the leg, squeezing the blood back toward the heart. They're often recommended for expectant mothers, people with varicose veins, post-op patients, and older people, who may need extra help with healthy blood flow. The feeling of pain relief you might get from wearing compression socks can be a result of better circulation in your legs, lower inflammation, and less stress on your muscles, Dr. Anahita Dua, a vascular surgeon at Massachusetts General Hospital and professor of surgery at Harvard Medical School, told BI. A younger consumer base Like Garfield, Sam Sarabi, a 25-year-old nurse from Temple, Texas, told BI she started experimenting with compression socks in 2023. She was searching for a way to help ease the pain she experienced in her thighs and calves, which popped up in the middle of her shifts and persisted when she got home. She didn't find a compression product that worked for her until Julia Gretars, a nursing student she connected with online and the founder of Juy Compression, sent her a pair of the brand's compression sleeves in November 2024. The sleeves are like compression socks, but they don't have feet. She said the sleeves leave her pain-free and with more energy. "I noticed a difference within the first day," Sarabi said. There's not much evidence that compression socks are good for already-healthy people who aren't struggling with swelling or circulation problems, but there's little downside as long as the socks fit well. Signs that you might benefit from compression socks include a feeling of tightness in the legs and feet, your shoes not fitting properly, and visible swelling (if you poke your leg with a finger, you'll see an imprint). There's still a good reason people in their 20s and 30s are stocking up on compression socks: they can be a game changer if you're pregnant or do a lot of exercise. For exercise, the evidence is growing that compression socks might have a small benefit for easing soreness after a workout, although they may not improve performance, according to Dua. The socks' squeezing effect on your legs mimics how your muscles naturally help to pump blood during active recovery, like walking, flushing out by-products of hard exercise like lactate to ease soreness and get you back to the gym faster. "It definitely wouldn't hurt if someone has low-grade inflammation after a run," physical therapist Jessica Chellsen said. Compression socks got a glow-up The compression sock renaissance is, in part, driven by new brands that appeal to younger consumers. For instance, in 2016, then-30-year-old Andrew Ferenci founded Comrad, a popular compression socks company, because he couldn't find an aesthetically pleasing version. The socks helped with his aches from travel and working out, but the plain black and beige pairs he found at Duane Reade left something to be desired. Ferenci said he created Comrad to offer a "compression sock that has all the benefits of a medical product and meets all the requirements, but is stylish and functional and has all the benefits of a lifestyle or athletic sock that you would wear." Ferenci told BI that millennials make up most of Comrad's customer base, but its products are also gaining popularity with Gen Z shoppers. The other major player is Bombas. Some of its socks are designed for everyday wear, and others for health or exercise support. Bombas offers new colors and patterns every season. Tam Conlin, Bombas' senior vice president of merchandising and design, told BI its compression products, which were first introduced in 2019, have grown 231% in the past three years, and the category is plus 31% for 2025 alone. BI couldn't independently confirm those percentages. Conlin also said millennial shoppers make up Bombas' biggest growth market. Conlin thinks compression socks are resonating with younger consumers because they are interested in "products that help you live more healthfully." "I think that mindset and consumer behavior is something that's really been taken on by the millennial generation and Gen Z, where there's specific products for specific needs that can really help you, and it's kind of like a life hack," she said. Garfield, who wears Bombas' compression socks, said the look is a game changer. "I think I used to hide them or want to not have them as visible, but they just look like socks. And they're cute," she said. Sarabi is also excited that more compression products are on the market, particularly in cuter styles. "In the majority of healthcare systems, you can only wear one color," she said. "I think if you could bring in a little bit of personality to design, it makes things fun." How to pick the right compression socks for you Here are some tips if you want to get in on the trend: Find the right fit and pressure. Look for socks that are snug but don't completely cut off your circulation. Avoid compression if you have difficulties with wound healing, and ask your doctor if you're unsure whether compression socks are right for you. Don't scrunch them up. Make sure they're aligned with your foot and aren't too long or too short so they can work as designed.
